share_log

B of A Securities Upgrades 10x Genomics to Neutral, Raises Price Target to $54

Benzinga ·  Dec 12, 2023 07:27

B of A Securities analyst Derik De Bruin upgrades 10x Genomics (NASDAQ:TXG) from Underperform to Neutral and raises the price target from $36 to $54.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment